GEN-MKT-18-7897-A
Aug 10, 2017 | Blogs, Life Science Research, Metabolomics | 0 comments
I recently had the opportunity to catch up with Baljit Ubhi to discuss the top questions you’re asking in regards to using Microflow HILIIC Chromatography for Targeted Metabolomics. Here’s what Bal said:
Many of the metabolites of interest in the study of metabolomics are extremely polar and therefore often unable to be analyzed through traditional coupling of reversed phase (RP) chromatography and mass spectrometry. Also to detect and quantify key metabolites from pathways of biochemical importance, samples must be run on both reversed phase and normal phase, in negative and positive ion modes requiring a total of four injections.
We have implemented hydrophilic chromatography (HILIC) with microflow and mass spectrometry to develop a method for screening over 300 polar metabolites. HILIC allows separation by partitioning of analytes between an aqueous enriched layer of a polar stationary phase. HILIC conditions typically use high organic, with a moderate amount of a salt (i.e. 20-100mM ammonium formate or acetate, pH 4.4 or 5.5. respectively). This method deviates by having 20 mM ammonium hydroxide in both mobile phases to provide constant pH of 9.0 during the chromatographic separation. The high pH deprotonates the stationary phase and allows for better selectivity of the polar metabolites. The method is multiple reaction monitoring (MRM) with positive/negative polarity switching allowing the collection of these key metabolites in a single injection!
While microflow has become increasingly popular for many applications, microflow for metabolomics has not been readily employed because the typically used (aqueous) sample solvent does not allow for injecting larger volumes of samples without sacrificing chromatographic resolution. However, by simply reconstituting the sample in an organic solvent (95% acetonitrile, pH 9), we were able to inject up to 5 µL onto the microLC column, while maintaining excellent peak shape.
The microflow Luna-NH2 HILIC chromatography provides excellent chromatographic separation of polar, hydrophilic metabolites. The cross-linked aminopropyl phase gives a slightly different selectivity than the traditional amide phase; it gives higher coverage of the metabolome when compared to the amide functionality. This allows for improved sensitivity with signal-to-noise (S/N) improvement of up to 60X and up to 50% higher coverage of the metabolome than traditional analytical approaches (see table above).
In monoclonal antibody (mAb) development, assessment of purity and integrity of the protein in question is critical. CE‑SDS is the gold standard assay and is routinely run from analytical development through QC and lot release. It’s trusted because it consistently delivers quantitative, size‑based insight into purity and fragmentation, and it fits naturally into regulated environments.
In drug discovery and development, Metabolite Identification (Met ID) plays a critical role in understanding biotransformation pathways, ensuring safety, and meeting regulatory requirements. Advanced mass spectrometry techniques have revolutionized this process, particularly through electron-based fragmentation methods such as Electron Activated Dissociation (EAD) and Electron Transfer Dissociation (ETD). While both techniques leverage electron interactions to generate informative fragment ions, they differ significantly in mechanism, performance, and suitability for Met ID workflows.
In analytical laboratories, performance is not optional. Whether supporting regulated pharmaceutical workflows, high-throughput CRO operations, clinical reporting, or food and environmental testing, your mass spectrometry and capillary electrophoresis systems are critical to productivity, compliance, and scientific confidence.
Posted by
You must be logged in to post a comment.
Share this post with your network